Skip to content
Clinical Trials – home

Pneumologisches Forschungsinstitut Hohegeest GbR

Research site

Germany Bohnenstr. 1, 21502 Geesthacht, Germany

  • 2 trials recruiting
  • Asthma · Cough · Bronchiectasis
  • Adults and children

About Specializations

Pneumologisches Forschungsinstitut Hohegeest GbR in Geesthacht, Germany specialises in clinical trials of conditions such as Asthma, Cough, Bronchiectasis, Chronic obstructive pulmonary disease, and other specialisations. This site conducts important research.

Main research areas of the site

Allergy and Immunotherapy

The medical center is at the forefront of research in allergy and immunotherapy, focusing on innovative treatments for conditions such as allergic rhinitis and rhinoconjunctivitis induced by house dust mite allergies. The center's work in this area aims to improve the quality of life for patients suffering from moderate to severe allergic reactions.

  • Subcutaneous Immunotherapy
  • Allergic Rhinitis and Rhinoconjunctivitis
  • House Dust Mite Allergy
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Bohnenstr. 121502 GeesthachtGermany
Recruiting now
2 trials
Conditions studied
6

More sites in GeesthachtGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

7 clinical trials

Bronchiectasis

Recruiting

A study testing GSK3862995B compared to placebo for safety and effectiveness in adults aged 18 to 85 years with bronchiectasis

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:GSK3862995B
  • Sponsor:GSK PLC

A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited

Conjunctivitis allergic+1

Not recruiting

Study on the Effectiveness of PURETHAL Mites for Adults with Moderate to Severe Allergic Rhinitis or Rhinoconjunctivitis Due to House Dust Mite Allergy

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Aluminium Hydroxide
  • Sponsor:HAL Allergy B.V.

Cough

Not recruiting

Study on the Effectiveness and Safety of Taplucainium Inhalation Powder (NOC-110) for Adults with Refractory or Unexplained Chronic Cough

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Taplucainium Chloride
  • Sponsor:Nocion Therapeutics Inc.

Cough

Not recruiting

Study on the Effectiveness and Safety of Camlipixant for Adults with Refractory or Unexplained Chronic Cough

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Camlipixant
  • Sponsor:Bellus Health Inc.

Asthma

Not recruiting

Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma

Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Asthma

Not recruiting

Study Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma

Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:Glaxosmithkline Research & Development Limited
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.